Generic Tazarotene Cream, 0.05% for the Treatment of Plaque Psoriasis

Last updated: March 19, 2014
Sponsor: G & W Laboratories Inc.
Overall Status: Active - Not Recruiting

Phase

3

Condition

Skin Wounds

Psoriasis And Psoriatic Disorders

Rosacea

Treatment

N/A

Clinical Study ID

NCT02093208
SYM 2013-01
  • Ages > 18
  • Both
  • Accepts Healthy Volunteers

Study Design

Total Participants: 804
Study Start date:
April 01, 2014
Estimated Completion Date:

Connect with a study center

  • Altman Dermatology Associates

    Arlington Heights, Illinois 60005
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.